Activated T cells play a pivotal role in allograft rejection. Upon activation T cells express gp39 a member of the TNF cytokine superfamily. CD40, the receptor for gp39 is expressed on a wide variety of cells, including dendritic cells, B cells, macrophages, endothelial cells (EC), and T cells. Evidence for the crucial role of gp39 in humoral immunity came from the recognition that the hyperIgM syndrome results from a defect in the gp39 gene. In addition, it has become increasingly apparent that CD4O also plays an important role in the regulation of macrophage, dendritic cell, EC and T cell function. Our central hypothesis is that the CD4O pathway plays a crucial role in the transition between the afferent and efferent phases of allograft rejection. In particular, CD40/gp39 signals are necessary for the delivery of cognate T cell help for effector cell activation and for T cell clonal expansion. We will address this hypothesis in the following specific aims: i) To define the kinetics and distribution of CD4O and gp39 expression during. allograft rejection. 2) To study the role of CD40/gp39 interactions in the T-dependent macrophage activation. Our hypothesis being that CD4O signals delivered during cognate interactions with T cells activate macrophage to express effector molecules and to exhibit effector functions. 3) To study the role of CD4O/gp39 interactions in the regulation of EC activation and leukocyte traffic during allograft rejection. We will test the hypothesis that CD4O/gp39 interactions play a critical role in the regulation of lymphocyte recruitment into allografts. 4) To study the role of CD40/gp39 interactions in the regulation of T cell clonal expansion. We hypothesize that CD4O signals antagonize pro-apoptotic signals delivered via the fas pathway. Deprivation of CD4O signals during T cell responses allows fas signals to predominate, leading to """"""""premature"""""""" activation-induced apoptosis, aborting clonal expansion. 5) To explore the mechanisms by which CTLA4-Ig and anti-gp39 synergize to inhibit allo-immune responses. Our hypothesis is that simultaneous blockade of CD28 and CD4O signals during antigen-challenge further shifts the balance toward accelerated fas-mediated activation-induced apoptosis. The CD4O pathway is distinct from other pathways previously targeted to inhibit allograft rejection. Unlike other agents anti-gp39 mAbs are not potent inhibitors of T cell activation. Rather CD4O appears to be a pivotal molecule in the transition from the afferent to the efferent phase of immune responses. As a regulator of many facets of T-dependent immune responses including T cell help for B cell, macrophage and EC activation, as well as T cell clonal expansion, further understanding the biology of the CD4O pathway promises to yield a new class of agents to therapeutically manipulate immune responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI040519-05
Application #
6328745
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Kehn, Patricia J
Project Start
1996-12-01
Project End
2001-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
5
Fiscal Year
2001
Total Cost
$582,323
Indirect Cost
Name
Emory University
Department
Surgery
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Adams, A B; Goldstein, J; Garrett, C et al. (2017) Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function. Am J Transplant 17:2922-2936
Ferrer, Ivana R; Wagener, Maylene E; Song, Minqing et al. (2011) Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A 108:20701-6
Turner, A P; Shaffer, V O; Araki, K et al. (2011) Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant 11:613-8
Reisman, Natalie M; Floyd, Tamara L; Wagener, Maylene E et al. (2011) LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function. Blood 118:5851-61
Ford, Mandy L; Larsen, Christian P (2011) Transplantation tolerance: memories that haunt us. Sci Transl Med 3:86ps22
Araki, Koichi; Gangappa, Shivaprakash; Dillehay, Dirck L et al. (2010) Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. J Exp Med 207:2355-67
Ford, Mandy L; Larsen, Christian P (2010) Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations. Curr Opin Organ Transplant 15:405-10
Araki, Koichi; Turner, Alexandra P; Shaffer, Virginia Oliva et al. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460:108-12
Gilson, Christopher R; Milas, Zvonimir; Gangappa, Shivaprakash et al. (2009) Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation. J Immunol 183:1625-35
Koehn, Brent H; Ford, Mandy L; Ferrer, Ivana R et al. (2008) PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. J Immunol 181:5313-22

Showing the most recent 10 out of 35 publications